Literature DB >> 10798807

Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant.

R G Stock1, N N Stone, Y C Lo.   

Abstract

PURPOSE: To describe a method of creating an intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant.
MATERIALS AND METHODS: An intraoperative dosimetry system (Multi Media Systems [MMS]) captures transverse ultrasound images after peripheral needles have been implanted in the prostate. The prostate contour and needle positions are outlined on the system. The volume of the prostate with needles in place is calculated. As seeds are deposited in the actual implant, the positions of the seeds are marked on the intraoperative system. Following implantation of the peripheral needles, the resulting isodose lines are displayed. The interior needles are inserted into the prostate, and these positions are captured on the system. As seeds are deposited through these needles into the prostate, their positions are captured on the planning system. When the implant is complete, the final dose coverage and dose volume histogram can be visualized.
RESULTS: Ten consecutive patients underwent iodine 125 implants using real-time intraoperative isodose generation. The ratio of the preneedle prostate volume to postneedle prostate volume ranged from 0.89 to 1.0 (median 0.97). The calculated dose delivered to 90% of the prostate volume from the dose volume histogram (D90) ranged from 146.5 to 194 Gy (median 174.75 Gy). The percentage of the prostate covered by 240 Gy ranged from 14.6% to 59% (median 40.75%).
CONCLUSION: Dosimetric representation of the real-time ultrasound-guided prostate implant can be achieved and demonstrates the efficacy of this brachytherapy technique.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10798807

Source DB:  PubMed          Journal:  Tech Urol        ISSN: 1079-3259


  7 in total

Review 1.  The efficacy of conventional external beam, three-dimensional conformal, intensity-modulated, particle beam radiation, and brachytherapy for localized prostate cancer.

Authors:  Tony Y Eng; Join Y Luh; Charles R Thomas
Journal:  Curr Urol Rep       Date:  2005-05       Impact factor: 3.092

2.  Needle position during (125)I seed implantation: accurately recognized by sagittal transrectal ultrasonography [corrected].

Authors:  Hiromichi Ishiyama; Shouko Kotani; Takefumi Satoh; Mineko Uemae; Shiro Baba; Kazushige Hayakawa
Journal:  Radiat Med       Date:  2008-10-31

3.  Long-term biochemical progression-free survival following brachytherapy for prostate cancer: Further insight into the role of short-term androgen deprivation and intermediate risk group subclassification.

Authors:  Haim Matzkin; Juza Chen; Rubi Agai; Tomer Ziv-Baran; Nicola J Mabjeesh
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

4.  Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy.

Authors:  Joshua Moorrees; John M Lawson; Loredana G Marcu
Journal:  Radiat Oncol       Date:  2012-11-22       Impact factor: 3.481

5.  Re-implantation of suboptimal prostate seed implantation: technique with intraoperative treatment planning.

Authors:  Laura Doyle; Adam J Hesney; Katherine L Chapman; Haisong Liu; Perry R Weiner; Adam P Dicker; Yan Yu; Timothy N Showalter
Journal:  J Contemp Brachytherapy       Date:  2012-09-29

Review 6.  Permanent seed implantation for localized adenocarcinoma of the prostate.

Authors:  Nelson N Stone; Richard G Stock
Journal:  Curr Urol Rep       Date:  2002-06       Impact factor: 2.862

7.  Comparison between preoperative and real-time intraoperative planning ¹²⁵I permanent prostate brachytherapy: long-term clinical biochemical outcome.

Authors:  Haim Matzkin; Juza Chen; Larissa German; Nicola J Mabjeesh
Journal:  Radiat Oncol       Date:  2013-12-17       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.